| EMA number | EMEA/H/C/000542 |
| ATC code | L04AA21 |
| Authorisation | 20 September 2004 |
| Withdrawn | 9 June 2009 |
| Revision | 8 |
Treatment of adult patients with moderate to severe chronic plaque psoriasis who have failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapies including ciclosporin, methotrexate and PUVA (see section 5.1 - Clinical Efficacy).